Search

Eurofins Scientific SE

Închisă

59.96 -2.19

Rezumat

Modificarea prețului

24h

Curent

Minim

59.94

Maxim

61.54

Indicatori cheie

By Trading Economics

Venit

-62M

123M

Vânzări

-1.7B

1.8B

P/E

Medie Sector

27.128

22.347

EPS

1.16

Randament dividend

0.95

Marjă de profit

6.827

Angajați

65,000

EBITDA

-276M

409M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+8.77% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.95%

4.41%

Statistici piață

By TradingEconomics

Capitalizare de piață

-706M

11B

Deschiderea anterioară

62.15

Închiderea anterioară

59.96

Scor tehnic

By Trading Central

Încredere

Weak Bearish Evidence

Eurofins Scientific SE Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

3 nov. 2025, 21:44 UTC

Câștiguri

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 nov. 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 nov. 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 nov. 2025, 23:28 UTC

Câștiguri

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 nov. 2025, 23:24 UTC

Câștiguri

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 nov. 2025, 23:14 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

3 nov. 2025, 23:14 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 nov. 2025, 23:12 UTC

Câștiguri

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 nov. 2025, 23:09 UTC

Câștiguri

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 nov. 2025, 23:09 UTC

Câștiguri

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 nov. 2025, 23:09 UTC

Câștiguri

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 nov. 2025, 23:06 UTC

Market Talk
Câștiguri

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 nov. 2025, 22:36 UTC

Market Talk
Câștiguri

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 nov. 2025, 22:31 UTC

Câștiguri

Franco-Nevada 3Q EPS $1.49 >FNV

3 nov. 2025, 22:31 UTC

Câștiguri

Franco-Nevada 3Q Rev $487.7M >FNV

3 nov. 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 nov. 2025, 22:19 UTC

Achiziții, Fuziuni, Preluări

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 nov. 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 nov. 2025, 21:54 UTC

Market Talk
Câștiguri

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 nov. 2025, 21:54 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

3 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 nov. 2025, 21:49 UTC

Câștiguri

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 nov. 2025, 21:40 UTC

Câștiguri

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 nov. 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 nov. 2025, 21:19 UTC

Câștiguri

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 nov. 2025, 21:11 UTC

Achiziții, Fuziuni, Preluări

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 nov. 2025, 21:11 UTC

Câștiguri

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 nov. 2025, 21:07 UTC

Câștiguri

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 nov. 2025, 21:05 UTC

Câștiguri

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 nov. 2025, 21:05 UTC

Câștiguri

Palantir Technologies 3Q Net $475.6M >PLTR

Eurofins Scientific SE Așteptări

Obiectiv de preț

By TipRanks

8.77% sus

Prognoză pe 12 luni

Medie 66.5 EUR  8.77%

Maxim 72 EUR

Minim 61 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEurofins Scientific SE - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

54.22 / 56.82Suport & Rezistență

Termen scurt

Weak Bearish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat